Corrigendum to "Ca2+/recoverin dependent regulation of phosphorylation of the rhodopsin mutant R135L associated with retinitis pigmentosa" [Biochem. Biophys. Res. Commun. 349 (2006) 345-352] (DOI:10.1016/j.bbrc.2006.08.048);Ca2+/recoverin dependent regulation of phosphorylation of the rhodopsin mutant R135L associated with retinitis pigmentosa

Biochemical and Biophysical Research Communications

Volumn 349, Issue 1, 2006, Pages 345-352

  Senin, Ivan I ^a,b   Bosch, Laia ^a,b   Ramon, Eva ^a,b   Zernii, Evgeni Yu ^a,b   Manyosa, Joan ^b,c   Philippov, Pavel P ^a,b   Garriga, Pere ^a,b  

^a UNIVERSITAT POLITÈCNICA DE CATALUNYA   (Spain)

^b MOSCOW STATE UNIVERSITY   (Russian Federation)

^c UNIVERSITAT AUTÒNOMA DE BARCELONA   (Spain)

Author keywords

Calcium; Recoverin; Retinitis pigmentosa; Rhodopsin kinase; Rhodopsin mutation; Rhodopsin phosphorylation; Transducin activation; Visual phototransduction

Indexed keywords

CALCIUM; GUANINE NUCLEOTIDE BINDING PROTEIN; RECOVERIN; RHODOPSIN; RHODOPSIN KINASE; TRANSDUCIN;

ANIMAL CELL; ARTICLE; AUTOSOMAL DOMINANT DISORDER; CELL DEGENERATION; CONTROLLED STUDY; DISEASE ASSOCIATION; GENE MUTATION; NONHUMAN; PHOTORECEPTOR; PRIORITY JOURNAL; PROTEIN PHOSPHORYLATION; RETINITIS PIGMENTOSA; ANIMAL; CATTLE; CELL STRAIN COS1; CERCOPITHECUS; CHEMISTRY; DOMINANT GENE; DOSE RESPONSE; GENETICS; METABOLISM; MUTATION; PHOSPHORYLATION;

ANIMALS; CALCIUM; CATTLE; CERCOPITHECUS AETHIOPS; COS CELLS; DOSE-RESPONSE RELATIONSHIP, DRUG; GENES, DOMINANT; MUTATION; PHOSPHORYLATION; RECOVERIN; RETINITIS PIGMENTOSA; RHODOPSIN; RHODOPSIN KINASE; TRANSDUCIN;

EID: 33748317961     PISSN: 0006291X     EISSN: 10902104     Source Type: Journal    
DOI: 10.1016/j.bbrc.2006.09.050     Document Type: Erratum

References (49)

1. Rivolta C., Sharon D., DeAngelis M.M., and Dryja T.P. Retinitis pigmentosa and allied diseases: numerous diseases, genes, and inheritance patterns. Hum. Mol. Genet. 11 (2002) 1219-1227
2. Kennan A., Aherne A., and Humphries P. Light in retinitis pigmentosa. Trends Genet. 21 (2005) 103-110
3. Farrar G.J., McWilliam P., Bradley D.G., Kenna P., Lawler M., Sharp E.M., Humphries M.M., Eiberg H., Conneally P.M., Trofatter J.A., et al. Autosomal dominant retinitis pigmentosa: linkage to rhodopsin and evidence for genetic heterogeneity. Genomics 8 (1990) 35-40
4. Sung C.H., Schneider B.G., Agarwal N., Papermaster D.S., and Nathans J. Functional heterogeneity of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88 (1991) 8840-8844
5. Doi T., Molday R.S., and Khorana H.G. Role of the intradiscal domain in rhodopsin assembly and function. Proc. Natl. Acad. Sci. USA 87 (1990) 4991-4995
6. Kaushal S., and Khorana H.G. Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry 33 (1994) 6121-6128
7. Ramon E., del Valle L.J., and Garriga P. Molecular biology of retinitis pigmentosa: therapeutic implications. Curr. Pharmacogenomics 2 (2004) 339-349
8. Andres A., Garriga P., and Manyosa J. Altered functionality in rhodopsin point mutants associated with retinitis pigmentosa. Biochem. Biophys. Res. Commun. 303 (2003) 294-301
9. Bosch L., Ramon E., del Valle L.J., and Garriga P. Structural and functional role of helices I and II in rhodopsin. A novel interplay evidenced by mutations at Gly-51 and Gly-89 in the transmembrane domain. J. Biol. Chem. 278 (2003) 20203-20209
10. Ramon E., del Valle J.L., and Garriga P. Unusual thermal and conformational properties of the rhodopsin congenital night blindness mutant Thr-94 → Ile. J. Biol. Chem. 278 (2003) 6427-6432
11. Oprian D.D., Molday R.S., Kaufman R.J., and Khorana H.G. Expression of a synthetic bovine rhodopsin gene in monkey kidney cells. Proc. Natl. Acad. Sci. USA 84 (1987) 8874-8878
12. Molday R.S., and MacKenzie D. Monoclonal antibodies to rhodopsin: characterization, cross-reactivity, and application as structural probes. Biochemistry 22 (1983) 653-660
13. Briscoe A.D., Gaur C., and Kumar S. The spectrum of human rhodopsin disease mutations through the lens of interspecific variation. Gene 332 (2004) 107-118
14. Mendes H.F., van der Spuy J., Chapple J.P., and Cheetham M.E. Mechanisms of cell death in rhodopsin retinitis pigmentosa: implications for therapy. Trends Mol. Med. 11 (2005) 177-185
15. Garriga P., Liu X., and Khorana H.G. Structure and function in rhodopsin: correct folding and misfolding in point mutants at and in proximity to the site of the retinitis pigmentosa mutation Leu-125 → Arg in the transmembrane helix C. Proc. Natl. Acad. Sci. USA 93 (1996) 4560-4564
16. Liu X., Garriga P., and Khorana H.G. Structure and function in rhodopsin: correct folding and misfolding in two point mutants in the intradiscal domain of rhodopsin identified in retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 93 (1996) 4554-4559
17. Hwa J., Reeves P.J., Klein-Seetharaman J., Davidson F., and Khorana H.G. Structure and function in rhodopsin: further elucidation of the role of the intradiscal cysteines, Cys-110, -185, and -187, in rhodopsin folding and function. Proc. Natl. Acad. Sci. USA 96 (1999) 1932-1935
18. Rajan R.S., and Kopito R.R. Suppression of wild-type rhodopsin maturation by mutants linked to autosomal dominant retinitis pigmentosa. J. Biol. Chem. 280 (2005) 1284-1291
19. Lem J., and Fain G.L. Constitutive opsin signaling: night blindness or retinal degeneration?. Trends Mol. Med. 10 (2004) 150-157
20. Alfinito P.D., and Townes-Anderson E. Activation of mislocalized opsin kills rod cells: a novel mechanism for rod cell death in retinal disease. Proc. Natl. Acad. Sci. USA 99 (2002) 5655-5660
21. Tam B.M., Xie G., Oprian D.D., and Moritz O.L. Mislocalized rhodopsin does not require activation to cause retinal degeneration and neurite outgrowth in Xenopus laevis. J. Neurosci. 26 (2006) 203-209
22. Fain G.L. Why photoreceptors die (and why they don't). Bioessays 28 (2006) 344-354
23. Palczewski K. G protein-coupled receptor rhodopsin. Annu. Rev. Biochem. 75 (2006) 743-767
24. Sung C.H., Davenport C.M., Hennessey J.C., Maumenee I.H., Jacobson S.G., Heckenlively J.R., Nowakowski R., Fishman G., Gouras P., and Nathans J. Rhodopsin mutations in autosomal dominant retinitis pigmentosa. Proc. Natl. Acad. Sci. USA 88 (1991) 6481-6485
25. Macke J.P., Davenport C.M., Jacobson S.G., Hennessey J.C., Gonzalez-Fernandez F., Conway B.P., Heckenlively J., Palmer R., Maumenee I.H., Sieving P., et al. Identification of novel rhodopsin mutations responsible for retinitis pigmentosa: implications for the structure and function of rhodopsin. Am. J. Hum. Genet. 53 (1993) 80-89
26. Shi W., Sports C.D., Raman D., Shirakawa S., Osawa S., and Weiss E.R. Rhodopsin arginine-135 mutants are phosphorylated by rhodopsin kinase and bind arrestin in the absence of 11-cis-retinal. Biochemistry 37 (1998) 4869-4874
27. Ponjavic V., Abrahamson M., Andreasson S., Ehinger B., and Fex G. Autosomal dominant retinitis pigmentosa with a rhodopsin mutation (Arg-135-Trp). Disease phenotype in a Swedish family. Acta Ophthalmol. Scand. 75 (1997) 218-223
28. Pannarale M.R., Grammatico B., Iannaccone A., Forte R., DeBernardo C., Flagiello L., Vingolo E.M., and Del Porto G. Autosomal-dominant retinitis pigmentosa associated with an Arg-135-Trp point mutation of the rhodopsin gene. Clinical features and longitudinal observations. Ophthalmology 103 (1996) 1443-1452
29. Andreasson S., Ehinger B., Abrahamson M., and Fex G. A six-generation family with autosomal dominant retinitis pigmentosa and a rhodopsin gene mutation (arginine-135-leucine). Ophthalmic. Paediatr. Genet. 13 (1992) 145-153
30. Oh K.T., Oh D.M., Weleber R.G., Stone E.M., Parikh A., White J., Deboer-Shields K.A., Streb L., and Vallar C. Genotype-phenotype correlation in a family with Arg135Leu rhodopsin retinitis pigmentosa. Br. J. Ophthalmol. 88 (2004) 1533-1537
31. Chuang J.Z., Vega C., Jun W., and Sung C.H. Structural and functional impairment of endocytic pathways by retinitis pigmentosa mutant rhodopsin-arrestin complexes. J. Clin. Invest. 114 (2004) 131-140
32. Greenberg J., Goliath R., Beighton P., and Ramesar R. A new locus for autosomal dominant retinitis pigmentosa on the short arm of chromosome 17. Hum. Mol. Genet. 3 (1994) 915-918
33. Bayes M., Valverde D., Balcells S., Grinberg D., Vilageliu L., Benitez J., Ayuso C., Beneyto M., Baiget M., and Gonzalez-Duarte R. Evidence against involvement of recoverin in autosomal recessive retinitis pigmentosa in 42 Spanish families. Hum. Genet. 96 (1995) 89-94
34. Parminder A.H., Murakami A., Inana G., Berson E.L., and Dryja T.P. Evaluation of the human gene encoding recoverin in patients with retinitis pigmentosa or an allied disease. Invest. Ophthalmol. Vis. Sci. 38 (1997) 704-709
35. Ohguro H., and Nakazawa M. Pathological roles of recoverin in cancer-associated retinopathy. Adv. Exp. Med. Biol. 514 (2002) 109-124
36. 2+-binding sites. J. Biol. Chem. 277 (2002) 50365-50372
37. 2+-myristoyl switch in a recoverin mutant. J. Mol. Biol. 330 (2003) 409-418
38. Pulvermüller A., Palczewski K., and Hofmann K.P. Interaction between photoactivated rhodopsin and its kinase: stability and kinetics of complex formation. Biochemistry 32 (1993) 14082-14088
39. Senin I.I., Dean K.R., Zargarov A.A., Akhtar M., and Philippov P.P. Recoverin inhibits the phosphorylation of dark-adapted rhodopsin more than it does that of bleached rhodopsin: a possible mechanism through which rhodopsin kinase is prevented from participation in a side reaction. Biochem. J. 321 (1997) 551-555
40. Kuhn H. Light- and GTP-regulated interaction of GTPase and other proteins with bovine photoreceptor membranes. Nature 283 (1980) 587-589
41. Min M.C., Zvyaga T.A., Cypess A.M., and Sakmar T.P. Characterization of mutant rhodopsins responsible for autosomal dominant retinitis pigmentosa. Mutations on the cytoplasmic surface affect transducin activation. J. Biol. Chem. 268 (1993) 9400-9404
42. Grossfield A., Feller S.E., and Pitman M.C. A role for direct interactions in the modulation of rhodopsin by omega-3 polyunsaturated lipids. Proc. Natl. Acad. Sci. USA 103 (2006) 4888-4893
43. Ramon E., Marron J., del Valle L.J., Bosch L., Andres A., Manyosa J., and Garriga P. Effect of dodecyl maltoside detergent on rhodopsin stability and function. Vision Res. 43 (2003) 3055-3061
44. Anderson R.E., and Penn J.S. Environmental light and heredity are associated with adaptive changes in retinal DHA levels that affect retinal function. Lipids 39 (2004) 1121-1124
45. Feller S.E., and Gawrisch K. Properties of docosahexaenoic-acid-containing lipids and their influence on the function of rhodopsin. Curr. Opin. Struct. Biol. 15 (2005) 416-422
46. Dizhoor A.M., Ray S., Kumar S., Niemi G., Spencer M., Brolley D., Walsh K.A., Philipov P.P., Hurley J.B., and Stryer L. Recoverin: a calcium sensitive activator of retinal rod guanylate cyclase. Science 251 (1991) 915-918
47. 2+! The physiology and pathology of Ca(2+)-binding proteins in the retina. Trends Neurosci. 19 (1996) 547-554
48. 2+-binding sites of recoverin exclusively controls interaction with rhodopsin kinase. Biol. Chem. 386 (2005) 285-289
49. Higgins M.K., Oprian D.D., and Schertler G.F. Recoverin binds exclusively to an amphipathic peptide at the N-terminus of rhodopsin kinase, inhibiting rhodopsin phosphorylation without affecting catalytic activity of the kinase. J. Biol. Chem. 281 (2006) 19426-19432